Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.

Dharmapatni AA, Smith MD, Crotti TN, Holding CA, Vincent C, Weedon HM, Zannettino AC, Zheng TS, Findlay DM, Atkins GJ, Haynes DR.

Arthritis Res Ther. 2011 Mar 24;13(2):R51. doi: 10.1186/ar3294.

2.

TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade.

van Kuijk AW, Wijbrandts CA, Vinkenoog M, Zheng TS, Reedquist KA, Tak PP.

Ann Rheum Dis. 2010 Jan;69(1):301-4. doi: 10.1136/ard.2008.090548. Epub .

3.

Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.

Kamijo S, Nakajima A, Kamata K, Kurosawa H, Yagita H, Okumura K.

Rheumatology (Oxford). 2008 Apr;47(4):442-50. doi: 10.1093/rheumatology/ken006. Epub 2008 Feb 29.

4.

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.

Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N.

Arthritis Rheum. 2001 May;44(5):1003-12.

5.

Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.

Kataria NG, Bartold PM, Dharmapatni AA, Atkins GJ, Holding CA, Haynes DR.

J Periodontal Res. 2010 Aug;45(4):564-73. doi: 10.1111/j.1600-0765.2010.01275.x. Epub 2010 Jun 10.

PMID:
20546112
6.

The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.

Pierer M, Brentano F, Rethage J, Wagner U, Hantzschel H, Gay RE, Gay S, Kyburz D.

Rheumatology (Oxford). 2007 Jul;46(7):1063-70. Epub 2007 Apr 10.

7.

TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.

Park JS, Park MK, Lee SY, Oh HJ, Lim MA, Cho WT, Kim EK, Ju JH, Park YW, Park SH, Cho ML, Kim HY.

Cytokine. 2012 Oct;60(1):143-9. doi: 10.1016/j.cyto.2012.06.285. Epub 2012 Jul 21.

PMID:
22819243
8.
9.

TWEAK promotes osteoclastogenesis in rheumatoid arthritis.

Park JS, Kwok SK, Lim MA, Oh HJ, Kim EK, Jhun JY, Ju JH, Park KS, Park YW, Park SH, Kim HY, Cho YG, Cho ML.

Am J Pathol. 2013 Sep;183(3):857-67. doi: 10.1016/j.ajpath.2013.05.027. Epub 2013 Jul 8.

PMID:
23845567
10.

Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.

Skoumal M, Kolarz G, Haberhauer G, Woloszczuk W, Hawa G, Klingler A.

Rheumatol Int. 2005 Nov;26(1):63-9. Epub 2005 May 12.

PMID:
15889303
12.

Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis.

Zhu LJ, Dai L, Zheng DH, Mo YQ, Ou-Yang X, Wei XN, Shen J, Zhang BY.

Arthritis Res Ther. 2012 Jun 4;14(3):R133. doi: 10.1186/ar3866.

13.

Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.

Dickerson TJ, Suzuki E, Stanecki C, Shin HS, Qui H, Adamopoulos IE.

J Autoimmun. 2012 Dec;39(4):369-76. doi: 10.1016/j.jaut.2012.06.001. Epub 2012 Aug 3.

14.

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.

Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S.

J Bone Miner Res. 1996 Jan;11(1):88-95.

PMID:
8770701
15.

Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.

Blaschke S, Schulz H, Schwarz G, Blaschke V, Müller GA, Reuss-Borst M.

J Rheumatol. 2001 Jan;28(1):12-21.

PMID:
11196512
16.

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.

Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.

Arthritis Rheum. 2000 Feb;43(2):259-69.

17.

RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.

Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.

Rheumatology (Oxford). 2006 Sep;45(9):1068-76. Epub 2006 Feb 20.

18.
19.
20.

Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls.

Haynes DR, Barg E, Crotti TN, Holding C, Weedon H, Atkins GJ, Zannetino A, Ahern MJ, Coleman M, Roberts-Thomson PJ, Kraan M, Tak PP, Smith MD.

Rheumatology (Oxford). 2003 Jan;42(1):123-34.

Items per page

Supplemental Content

Write to the Help Desk